内視鏡的逆行性胆管膵管造影市場：製品、手技、エンドユーザー別-2023-2030年の世界予測

内視鏡的逆行性胆管膵管造影の世界市場は、2023年に19億1,882万米ドル、CAGR7.52％で大きく成長し、2030年には32億245万米ドルに達すると予測されています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは世界の内視鏡的逆行性胆管膵管造影市場を評価するために不可欠です。事業戦略と製品満足度の主要指標を調査することで、ベンダーの包括的な評価を提供し、ユーザーは特定のニーズに基づいた情報をもとに意思決定を行うことができます。この高度な分析により、ベンダーは成功の度合いが異なる4つの象限に整理されます：フォアフロント（F）、パスファインダー（P）、ニッチ（N）、バイタル（V）です。

市場シェア分析

市場シェア分析では、特定の市場領域におけるベンダーの現状を洞察することができます。全体的な収益、顧客基盤、その他の主要指標に対するベンダーの貢献度を比較することで、企業が市場シェアを争う際に、自社の業績や直面している状況をより深く理解することができます。また、本分析では、調査した基準年において、特定のセクターがどの程度競合しているのか、蓄積、断片化の優位性、合併の特徴についても明らかにしています。

本レポートは、以下のポイントに関する洞察を提供します：

1.市場の浸透度：主要企業が提供する市場に関する包括的な情報を提供します。

2.市場の発展：有利な新興市場に関する詳細情報を提供し、市場の成熟セグメントにおける浸透度を分析します。

3.市場の多様化：新製品の上市、未開発地域、最近の開発、投資に関する詳細情報を提供します。

4.市場の動向：COVID-19、ロシア・ウクライナ紛争、高インフレの累積的な影響を包括的に理解することができます。

5.競合の評価と情報：主要企業の市場シェア、戦略、製品、認証、規制状況、特許状況、製造能力を網羅的に評価します。

6.製品開発およびイノベーション：将来技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような質問にお答えします：

1.内視鏡的逆行性胆管膵管造影の世界市場規模および予測は？

2.予測期間中、世界の内視鏡的逆行性胆管膵管造影市場を形成するCOVID-19の阻害要因と影響は？

3.内視鏡的逆行性胆管膵管造影の世界市場において予測期間中に投資すべき製品/セグメント/アプリケーション/分野は？

4.内視鏡的逆行性胆管膵管造影の世界市場における競争戦略は？

5.内視鏡的逆行性胆管膵管造影の世界市場における技術動向と規制の枠組みは？

6.内視鏡的逆行性胆管膵管造影の世界市場における主要ベンダーの市場シェアは？

7.内視鏡的逆行性胆管膵管造影の世界市場への参入には、どのような形態や戦略的な動きが適していると考えられるか？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 胃腸障害および慢性胆管障害の有病率の増加
    • 世界中のヘルスケアインフラの強化に伴うヘルスケア支出の急増
    • 高度な内視鏡技術に対する消費者の意識の高まりと相まって、低侵襲手術に対する嗜好の高まり
  • 抑制要因
    • 内視鏡的逆行性胆管膵管造影デバイスに関連する高コスト
  • 機会
    • 内視鏡処置の進歩のために多額の投資を行った重要な研究開発活動
    • 政府の好意的な措置により、内視鏡的逆行性胆管膵管造影ソリューションの導入が継続的に急増
  • 課題
    • 世界中で熟練した専門家と訓練を受けた内視鏡医が不足している
• 市場動向
• COVID-19の累積的な影響
• ロシア・ウクライナ紛争の累積的影響
• 高インフレの累積的影響
• ポーターのファイブフォース分析
• バリューチェーンとクリティカルパス分析
• 規制の枠組み
• 顧客のカスタマイズ

第6章 内視鏡的逆行性胆管膵管造影市場：製品別

• 内視鏡
• 内視鏡治療装置
  • バルーン
  • バスケット
  • カニューレ
  • カテーテル
  • 鉗子
  • ガイドワイヤー
  • 砕石器
  • スネア
  • 括約筋切開術
  • ステント
• エネルギーデバイス
• 可視化システム

第7章 内視鏡的逆行性胆管膵管造影市場手順別

• 胆道拡張
• 胆道括約筋切開術
• 胆管ステント留置術
• 膵管拡張
• 膵管ステント留置術
• 膵臓括約筋切開術

第8章 内視鏡的逆行性胆管膵管造影市場：エンドユーザー別

• 外来手術センターおよびクリニック
• 病院

第9章 南北アメリカの内視鏡的逆行性胆管膵管造影市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第10章 アジア太平洋地域の内視鏡的逆行性胆管膵管造影市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第11章 欧州・中東・アフリカの内視鏡的逆行性胆管膵管造影市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第12章 競合情勢

• FPNVポジショニングマトリクス
• 市場シェア分析：主要企業別
• 競合シナリオ分析：主要企業別

第13章 掲載企業一覧

第14章 付録

• ディスカッションガイド
• ライセンスと価格について

LIST OF FIGURES

• FIGURE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET RESEARCH PROCESS
• FIGURE 2. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2022 VS 2030
• FIGURE 3. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2022 VS 2030 (%)
• FIGURE 5. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2022 VS 2030 (%)
• FIGURE 6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2022 VS 2030 (%)
• FIGURE 7. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY REGION, 2022 VS 2030 (%)
• FIGURE 8. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET DYNAMICS
• FIGURE 9. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 10. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 11. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 12. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 13. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 14. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 15. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
• FIGURE 16. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2022
• FIGURE 17. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

• TABLE 1. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
• TABLE 3. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 5. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOSCOPES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 6. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 7. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 8. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BALLOONS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BASKETS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CANNULAS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY CATHETERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 12. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY FORCEPS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY GUIDING WIRES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY LITHOTRIPTER, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SNARES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY SPHINCTEROTOMES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STENTS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENERGY DEVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY VISUALIZATION SYSTEMS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 21. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY DILATATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY BILIARY STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT DILATATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC DUCT STENTING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 26. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PANCREATIC SPHINCTEROTOMY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 27. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY AMBULATORY SURGERY CENTRES & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 29. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 30. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 31. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 32. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 33. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 34. AMERICAS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 35. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 36. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 37. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 38. ARGENTINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 39. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 40. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 41. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 42. BRAZIL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 43. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 44. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 45. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 46. CANADA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 47. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 48. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 49. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 50. MEXICO ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 51. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 52. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 53. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 54. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 55. UNITED STATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 56. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 57. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 58. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 59. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 60. ASIA-PACIFIC ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 61. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 62. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 63. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 64. AUSTRALIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 65. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 66. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 67. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 68. CHINA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 69. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 70. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 71. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 72. INDIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 73. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 74. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 75. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 76. INDONESIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 77. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 78. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 79. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 80. JAPAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 81. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 82. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 83. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 84. MALAYSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 85. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 86. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 87. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 88. PHILIPPINES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 89. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 90. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 91. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 92. SINGAPORE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 93. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 94. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 95. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 96. SOUTH KOREA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 97. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 98. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 99. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 100. TAIWAN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 101. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 102. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 103. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 104. THAILAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 105. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 106. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 107. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 108. VIETNAM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 109. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 110. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 111. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 112. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 113. EUROPE, MIDDLE EAST & AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 114. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 115. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 116. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 117. DENMARK ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 118. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 119. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 120. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 121. EGYPT ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 122. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 123. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 124. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 125. FINLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 126. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 127. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 128. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 129. FRANCE ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 130. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 131. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 132. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 133. GERMANY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 134. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 135. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 136. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 137. ISRAEL ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 138. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 139. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 140. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 141. ITALY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 142. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 143. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 144. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 145. NETHERLANDS ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 146. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 147. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 148. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 149. NIGERIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 150. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 151. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 152. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 153. NORWAY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 154. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 155. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 156. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 157. POLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 158. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 159. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 160. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 161. QATAR ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 162. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 163. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 164. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 165. RUSSIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 166. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 167. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 168. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 169. SAUDI ARABIA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 170. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 171. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 172. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 173. SOUTH AFRICA ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 174. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 175. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 176. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 177. SPAIN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 178. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 179. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 180. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 181. SWEDEN ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 182. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 183. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 184. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 185. SWITZERLAND ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 186. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 187. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 188. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 189. TURKEY ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 190. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 191. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 192. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 193. UNITED ARAB EMIRATES ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 194. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 195. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY ENDOTHERAPY DEVICES, 2018-2030 (USD MILLION)
• TABLE 196. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY PROCEDURE, 2018-2030 (USD MILLION)
• TABLE 197. UNITED KINGDOM ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 198. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET, FPNV POSITIONING MATRIX, 2022
• TABLE 199. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET SHARE, BY KEY PLAYER, 2022
• TABLE 200. ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY MARKET LICENSE & PRICING

The Global Endoscopic Retrograde Cholangiopancreatography Market is forecasted to grow significantly, with a projected USD 1,918.82 million in 2023 at a CAGR of 7.52% and expected to reach a staggering USD 3,202.45 million by 2030.

The Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and High Inflation is expected to have significant long-term effects on the Global Endoscopic Retrograde Cholangiopancreatography Market. The ongoing research considers the changes in consumer behavior, supply chain disruptions, and government interventions caused by the pandemic. Similarly, the report considers the ongoing political and economic uncertainty in Eastern Europe caused by the Russia-Ukraine Conflict and its potential implications for demand-supply balances, pressure on pricing variants, and import/export and trading. Additionally, the report addresses the impact of High Inflation on the global economy and details fiscal policies measuring and reducing its effects on demand, supply, cash flow, and currency exchange.

Market Segmentation & Coverage:

This research report categorizes the Global Endoscopic Retrograde Cholangiopancreatography Market in order to forecast the revenues and analyze trends in each of following sub-markets:

Based on Product, market is studied across Endoscopes, Endotherapy Devices, Energy Devices, and Visualization Systems. The Endotherapy Devices is further studied across Balloons, Baskets, Cannulas, Catheters, Forceps, Guiding Wires, Lithotripter, Snares, Sphincterotomes, and Stents. The Endoscopes is projected to witness significant market share during forecast period.

Based on Procedure, market is studied across Biliary Dilatation, Biliary Sphincterotomy, Biliary Stenting, Pancreatic Duct Dilatation, Pancreatic Duct Stenting, and Pancreatic Sphincterotomy. The Biliary Dilatation is projected to witness significant market share during forecast period.

Based on End-User, market is studied across Ambulatory Surgery Centres & Clinics and Hospitals. The Ambulatory Surgery Centres & Clinics is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is essential for assessing the Global Endoscopic Retrograde Cholangiopancreatography Market. It provides a comprehensive evaluation of vendors by examining key metrics within Business Strategy and Product Satisfaction, allowing users to make informed decisions based on their specific needs. This advanced analysis then organizes these vendors into four distinct quadrants, which represent varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital(V).

Market Share Analysis:

The Market Share Analysis offers an insightful look at the current state of vendors in a particular market space. By comparing vendor contributions to overall revenue, customer base, and other key metrics, we can give companies a greater understanding of their performance and what they are up against when competing for market share. The analysis also sheds light on just how competitive any given sector is about accumulation, fragmentation dominance, and amalgamation traits over the base year period studied.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyzes penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments

4. Market Trends: Provides comprehensive understanding of the Cumulative Impact of COVID-19, the Russia-Ukraine Conflict, and the High Inflation

5. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

6. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Endoscopic Retrograde Cholangiopancreatography Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Endoscopic Retrograde Cholangiopancreatography Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Endoscopic Retrograde Cholangiopancreatography Market?

4. What is the competitive strategic window for opportunities in the Global Endoscopic Retrograde Cholangiopancreatography Market?

5. What are the technology trends and regulatory frameworks in the Global Endoscopic Retrograde Cholangiopancreatography Market?

6. What is the market share of the leading vendors in the Global Endoscopic Retrograde Cholangiopancreatography Market?

7. What modes and strategic moves are considered suitable for entering the Global Endoscopic Retrograde Cholangiopancreatography Market?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Limitations
• 1.7. Assumptions
• 1.8. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

• 4.1. Introduction
• 4.2. Endoscopic Retrograde Cholangiopancreatography Market, by Product, 2022 vs 2030
• 4.3. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure, 2022 vs 2030
• 4.4. Endoscopic Retrograde Cholangiopancreatography Market, by End-User, 2022 vs 2030
• 4.5. Endoscopic Retrograde Cholangiopancreatography Market, by Region, 2022 vs 2030

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Growing prevalence of gastrointestinal and chronic biliary disorders
    • 5.1.1.2. Proliferation in healthcare expenditures coupled with enhancing healthcare infrastructures worldwide
    • 5.1.1.3. Rising preference for minimally invasive surgeries coupled with increasing consumer awareness toward advanced endoscopic techniques
  • 5.1.2. Restraints
    • 5.1.2.1. High costs associated with endoscopic retrograde cholangiopancreatography devices
  • 5.1.3. Opportunities
    • 5.1.3.1. Significant research and development activities with heavy investments for advancement of endoscopic procedures
    • 5.1.3.2. Ongoing surge in deployment of endoscopic retrograde cholangiopancreatography solutions with favorable governmental actions
  • 5.1.4. Challenges
    • 5.1.4.1. Scarcity of skilled professionals and trained endoscopists across the globe
• 5.2. Market Trends
• 5.3. Cumulative Impact of COVID-19
• 5.4. Cumulative Impact of Russia-Ukraine Conflict
• 5.5. Cumulative Impact of High Inflation
• 5.6. Porter's Five Forces Analysis
  • 5.6.1. Threat of New Entrants
  • 5.6.2. Threat of Substitutes
  • 5.6.3. Bargaining Power of Customers
  • 5.6.4. Bargaining Power of Suppliers
  • 5.6.5. Industry Rivalry
• 5.7. Value Chain & Critical Path Analysis
• 5.8. Regulatory Framework
• 5.9. Client Customization

6. Endoscopic Retrograde Cholangiopancreatography Market, by Product

• 6.1. Introduction
• 6.2. Endoscopes
• 6.3. Endotherapy Devices
  • 6.3.1. Balloons
  • 6.3.2. Baskets
  • 6.3.3. Cannulas
  • 6.3.4. Catheters
  • 6.3.5. Forceps
  • 6.3.6. Guiding Wires
  • 6.3.7. Lithotripter
  • 6.3.8. Snares
  • 6.3.9. Sphincterotomes
  • 6.3.10. Stents
• 6.4. Energy Devices
• 6.5. Visualization Systems

7. Endoscopic Retrograde Cholangiopancreatography Market, by Procedure

• 7.1. Introduction
• 7.2. Biliary Dilatation
• 7.3. Biliary Sphincterotomy
• 7.4. Biliary Stenting
• 7.5. Pancreatic Duct Dilatation
• 7.6. Pancreatic Duct Stenting
• 7.7. Pancreatic Sphincterotomy

8. Endoscopic Retrograde Cholangiopancreatography Market, by End-User

• 8.1. Introduction
• 8.2. Ambulatory Surgery Centres & Clinics
• 8.3. Hospitals

9. Americas Endoscopic Retrograde Cholangiopancreatography Market

• 9.1. Introduction
• 9.2. Argentina
• 9.3. Brazil
• 9.4. Canada
• 9.5. Mexico
• 9.6. United States

10. Asia-Pacific Endoscopic Retrograde Cholangiopancreatography Market

• 10.1. Introduction
• 10.2. Australia
• 10.3. China
• 10.4. India
• 10.5. Indonesia
• 10.6. Japan
• 10.7. Malaysia
• 10.8. Philippines
• 10.9. Singapore
• 10.10. South Korea
• 10.11. Taiwan
• 10.12. Thailand
• 10.13. Vietnam

11. Europe, Middle East & Africa Endoscopic Retrograde Cholangiopancreatography Market

• 11.1. Introduction
• 11.2. Denmark
• 11.3. Egypt
• 11.4. Finland
• 11.5. France
• 11.6. Germany
• 11.7. Israel
• 11.8. Italy
• 11.9. Netherlands
• 11.10. Nigeria
• 11.11. Norway
• 11.12. Poland
• 11.13. Qatar
• 11.14. Russia
• 11.15. Saudi Arabia
• 11.16. South Africa
• 11.17. Spain
• 11.18. Sweden
• 11.19. Switzerland
• 11.20. Turkey
• 11.21. United Arab Emirates
• 11.22. United Kingdom

12. Competitive Landscape

• 12.1. FPNV Positioning Matrix
• 12.2. Market Share Analysis, By Key Player
• 12.3. Competitive Scenario Analysis, By Key Player

13. List of Company Mentioned

14. Appendix

• 14.1. Discussion Guide
• 14.2. License & Pricing